Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Insulet

Dow Jones Futures: Bulls Fight Back After Sell-Off, Palantir Leads; Government Shutdown Averted

Stock market bulls fought back Friday, mitigating a bearish week. Palantir was among the winners. A government shutdown crisis is over. Here's what to do now.

Investors Business Daily

Dow Jones Futures: CPI Inflation Due As Palantir, Nvidia Bounce

Dow Jones Futures: CPI Inflation Due As Palantir, Nvidia Bounce

Google broke out Tuesday as Tesla races. But Palantir, AppLovin and most growth stocks fell. CPI inflation data is on tap.

Investors Business Daily

Are Wall Street Analysts Predicting Insulet Stock Will Climb or Sink?

Are Wall Street Analysts Predicting Insulet Stock Will Climb or Sink?

As Insulet outperformed relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Dexcom Glucose Data To Be Integrated With ŌURA Rings

Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help improve consumers' metabolic health.

International Business Times

Insulet Joins Elite List Of Stocks With 95-Plus Composite Rating

Insulet saw an improvement in its IBD SmartSelect Composite Rating Monday, from 93 to 97.

Investors Business Daily

Stocks To Watch: Insulet Sees RS Rating Rise To 93

Insulet sees its Relative Strength Rating hit the elite 90-plus level.

Investors Business Daily

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024."

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Here Is Why Analysts See More Growth After Meta's Impressive Gains

Here Is Why Analysts See More Growth After Meta's Impressive Gains

Meta stock is just above a buy zone from a buy point at 544.23 ahead of earnings on Wednesday. Analysts see profits rising in fiscal 2024 and 2025.

Investors Business Daily

Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits

Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits

Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New Zealand is good news.

The Conversation

Is Insulet Stock Outperforming the Nasdaq?

Is Insulet Stock Outperforming the Nasdaq?

Insulet has outperformed the Nasdaq Composite over the past year and analysts remain strongly bullish about the stock’s prospects.

Stocks Close in the Red, Nvidia Trades Lower After Earnings Report

Stocks Close in the Red, Nvidia Trades Lower After Earnings Report

The Nasdaq 100 fell to a 2-week low on Wednesday, dragging down the broader market. Nvidia stock drops after the AI company released its earnings report.

Stocks Close Lower, Nvidia Trades Lower After Earnings Report

Stocks Close Lower, Nvidia Trades Lower After Earnings Report

The Nasdaq 100 fell to a 2-week low on Wednesday, dragging down the broader market. Nvidia stock drops after the AI company released its earnings report.

Stocks Close Lower Ahead of Nvidia Earnings

Stocks Close Lower Ahead of Nvidia Earnings

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.18%. Stocks settled lower Wednesday, with the Nasdaq 100 falling to a 2-week low. Weakness...

Broader Market Lower as Chip Stocks Tumble

Broader Market Lower as Chip Stocks Tumble

The S&P 500 Index ($SPX ) (SPY ) today is down -0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.81%. Weakness in chip stocks is weighing on the overall market ahead of quarterly earnings...

Get all your
news in one place.

100’s of premium titles.
One news app.

Stocks Mixed Ahead of Nvidia’s Earnings

The S&P 500 Index ($SPX ) (SPY ) today is down -0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.15%. US stocks today are narrowly mixed. Some mixed corporate news today is weighing on...

Is Wall Street Bullish or Bearish on Insulet Stock?

Despite Insulet’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Stocks Close Higher as Market Sentiment Improves

The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.54%. US stocks settled moderately higher on Friday due to an improvement in market sentiment....

Stocks Continue to Rebound in the Afternoon Trading Session

The S&P 500 Index ($SPX ) (SPY ) is up +0.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.75%. US stocks today are trading higher. Akamai Technologies is up more than +10% after reporting...

Get all your
news in one place.

100’s of premium titles.
One news app.

Stocks Waver on Mixed Corporate News

The S&P 500 Index ($SPX ) (SPY ) is up +0.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. US stocks today are trading between modest gains and losses due to mixed corporate news....

Stocks Undercut by Mixed Corporate News

The S&P 500 Index ($SPX ) (SPY ) is down -0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.10%. US stocks today are being undercut by mixed corporate news. Insulet is down more than...

Insulet's Q2 2024 Earnings: What to Expect

Insulet will release its second-quarter earnings next month, and analysts anticipate double-digit bottom-line growth.

Investors Business Daily

Stocks Showing Improved Relative Strength: Insulet

Insulet shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Insulet Forecasts Weak Revenue Growth, Shares Drop

Insulet Corporation faces challenges as it forecasts weak revenue growth due to market competition and supply chain issues.

Investors Business Daily

Insulet Surges After Eye-Popping Earnings Growth Wallops Expectations

Insulin pump-maker Insulet walloped earnings projections and delivered strong sales, leading PODD stock to jump Friday.

Investors Business Daily

Analysts Predict A 19% Surge For The S&P 500 Soon — Lifted By 10 Stocks

It's been a rough half of the year for the S&P 500 — with it slipping nearly 3%. But that's not stopping analysts from bullish calls.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Intel Corporation

Taiwan Semiconductor

Super Micro Computer

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Government Shutdown

Places

243,685 stories

Aotearoa New Zealand

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play